Ascentawits Pharmaceuticals
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A biotech firm creating small molecule therapies for cancer and autoimmune diseases through structure-based drug design.
OncologyImmunology
Technology Platform
An integrated platform combining structure-based drug design, computational chemistry, and translational models to develop oral small molecule therapeutics.
Opportunities
Potential to develop convenient oral alternatives to injectable biologics in large markets like oncology and autoimmunity.
Risk Factors
High risk of preclinical failure and significant challenges in achieving clinical validation for novel mechanisms of action.
Competitive Landscape
Faces competition from numerous well-funded biotechs globally and in China pursuing similar small molecule approaches in immuno-oncology.